Smithfield Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.9M Sell
5,934
-2,035
-26% -$1.1M 0.13% 93
2025
Q4
$4.62M Buy
7,969
+1,869
+31% +$1.06M 0.2% 71
2025
Q3
$2.96M Buy
6,100
+140
+2% +$65.2K 0.13% 89
2025
Q2
$2.41M Sell
5,960
-13
-0.2% -$5.43K 0.11% 95
2025
Q1
$2.95M Sell
5,973
-318
-5% -$172K 0.15% 82
2024
Q4
$3.27M Buy
6,291
+243
+4% +$134K 0.16% 83
2024
Q3
$3.73M Buy
6,048
+96
+2% +$56.8K 0.18% 80
2024
Q2
$3.29M Sell
5,952
-2
-0% -$1.15K 0.17% 73
2024
Q1
$3.47M Sell
5,954
-40
-0.7% -$22.4K 0.18% 75
2023
Q4
$3.18M Sell
5,994
-415
-6% -$201K 0.18% 78
2023
Q3
$3.26M Buy
6,409
+408
+7% +$217K 0.2% 73
2023
Q2
$3.13M Buy
6,001
+132
+2% +$71.2K 0.19% 75
2023
Q1
$3.39M Sell
5,869
-348
-6% -$196K 0.22% 64
2022
Q4
$3.43M Buy
6,217
+129
+2% +$68.4K 0.23% 68
2022
Q3
$3.1M Buy
6,088
+22
+0.4% +$12.3K 0.22% 65
2022
Q2
$3.29M Buy
6,066
+91
+2% +$50.1K 0.23% 60
2022
Q1
$3.54M Buy
5,975
+489
+9% +$281K 0.23% 63
2021
Q4
$3.66M Buy
5,486
+249
+5% +$155K 0.23% 66
2021
Q3
$3M Sell
5,237
-203
-4% -$111K 0.2% 70
2021
Q2
$2.75M Sell
5,440
-88
-2% -$41.5K 0.18% 78
2021
Q1
$2.52M Sell
5,528
-484
-8% -$231K 0.17% 75
2020
Q4
$2.8M Sell
6,012
-600
-9% -$281K 0.2% 71
2020
Q3
$2.92M Buy
6,612
+39
+0.6% +$16.1K 0.24% 67
2020
Q2
$2.38M Sell
6,573
-117
-2% -$39.2K 0.21% 72
2020
Q1
$1.9M Sell
6,690
-411
-6% -$130K 0.2% 72
2019
Q4
$2.31M Sell
7,101
-155
-2% -$47K 0.21% 75
2019
Q3
$2.11M Buy
7,256
+288
+4% +$82.5K 0.21% 74
2019
Q2
$2.05M Buy
6,968
+630
+10% +$174K 0.21% 69
2019
Q1
$1.74M Sell
6,338
-103
-2% -$25.6K 0.19% 75
2018
Q4
$1.44M Sell
6,441
-145
-2% -$34K 0.17% 79
2018
Q3
$1.61M Sell
6,586
-110
-2% -$25.3K 0.17% 82
2018
Q2
$1.39M Buy
6,696
+9
+0.1% +$1.91K 0.16% 83
2018
Q1
$1.38M Sell
6,687
-38
-0.6% -$7.98K 0.17% 82
2017
Q4
$1.28M Buy
6,725
+377
+6% +$72.2K 0.16% 91
2017
Q3
$1.2M Buy
6,348
+885
+16% +$160K 0.16% 87
2017
Q2
$953K Hold
5,463
0.14% 98
2017
Q1
$839K Sell
5,463
-95
-2% -$14.5K 0.13% 102
2016
Q4
$784K Sell
5,558
-51
-0.9% -$7.52K 0.13% 106
2016
Q3
$892K Sell
5,609
-49
-0.9% -$7.55K 0.16% 83
2016
Q2
$836K Buy
5,658
+29
+0.5% +$4.28K 0.16% 92
2016
Q1
$797K Buy
5,629
+475
+9% +$63.7K 0.16% 92
2015
Q4
$731K Buy
5,154
+84
+2% +$11.2K 0.15% 96
2015
Q3
$620K Buy
5,070
+120
+2% +$15.6K 0.13% 117
2015
Q2
$643K Sell
4,950
-50
-1% -$6.52K 0.13% 118
2015
Q1
$672K Buy
5,000
+4,400
+733% +$567K 0.13% 119
2014
Q4
$75K Hold
600
0.02% 450
2014
Q3
$73K Hold
600
0.01% 460
2014
Q2
$71K Hold
600
0.01% 490
2014
Q1
$72K Hold
600
0.01% 484
2013
Q4
$67K Hold
600
0.01% 476
2013
Q3
$55K Hold
600
0.01% 484
2013
Q2
$51K Buy
+600
New +$49.9K 0.01% 475

Other funds holding TMO

Smithfield Trust's TMO Position: Q1 2026 in Review

Smithfield Trust reduced its Thermo Fisher Scientific (TMO) stake by 26% in Q1 2026, selling an estimated $1.1M and leaving 5,934 shares worth $2.9M. The position accounts for 0.13% of the portfolio, ranked #93.

Smithfield Trust first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.62M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Smithfield Trust held 5,934 shares of Thermo Fisher Scientific worth $2.9M as of Q1 2026.
  • Smithfield Trust sold 2,035 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.1M.
  • Thermo Fisher Scientific made up 0.13% of Smithfield Trust's portfolio in Q1 2026, its #93 holding.
  • Smithfield Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Smithfield Trust's Thermo Fisher Scientific position peaked at $4.62M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.